Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Down 58.6% in July

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a significant decrease in short interest during the month of July. As of July 15th, there was short interest totaling 9,653 shares, a decrease of 58.6% from the June 30th total of 23,325 shares. Approximately 0.5% of the shares of the stock are sold short. Based on an average trading volume of 133,939 shares, the days-to-cover ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 25th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has an average rating of “Sell”.

Arcadia Biosciences Stock Performance

Shares of NASDAQ:RKDA opened at $0.64 on Monday. The company has a fifty day moving average of $0.81 and a 200-day moving average of $1.38. The company has a market capitalization of $1.40 million, a PE ratio of -0.11 and a beta of 0.54. Arcadia Biosciences has a 52-week low of $0.59 and a 52-week high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The firm had revenue of $1.10 million during the quarter, compared to the consensus estimate of $1.60 million.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.